12
Participants
Start Date
February 21, 2019
Primary Completion Date
April 6, 2019
Study Completion Date
June 4, 2019
PF-06651600 10 mg tablets
"On Day 1 in Period 1, a single oral dose of 30 mg (3 x 10 mg tablets) will be administered.~On Day 4 of Period 2, a single oral dose of 30 mg (3 x 10 mg tablets) will be administered after itraconazole."
Itraconazole Solution 200 mg
"Itraconazole 200 mg will be administered as 20 mL (10 mg/mL) oral solution once daily on Days 1-5 in Period 2.~On Day 4 of Period 2, co-administration of itraconazole 200 mg and PF-06651600 30 mg will occur. Itraconazole will be administered first followed by PF-06651600 tablets."
Pfizer Clinical Research Unit, Brussels
Lead Sponsor
Pfizer
INDUSTRY